Skip to main content
Alan P. Jacobsen

Alan P. Jacobsen, MB, BCh, BAO

Languages spoken: English

Academic Information

Departments Primary - Internal Medicine

Divisions: Cardiovascular Medicine

Board Certification

  • American Board of Internal Medicine (Internal Medicine)

Dr Alan Jacobsen MB. BCh. BAO. is an Assistant Professor at the University of Utah School of Medicine. He received his medical degree from the University of Galway, Ireland. He completed a combined Medical/Surgical internship at the Mater Misericordiae University Hospital, Dublin, Ireland and basic specialty training in General Internal Medicine at University Hospital Galway, Ireland. He completed Internal Medicine residency in the Osler Program at The Johns Hopkins Hospital, Maryland. He subsequently completed his Cardiovascular Disease fellowship at The Johns Hopkins Hospital where he received dedicated training in Sports Cardiology and Echocardiography.

Dr Jacobsen has a wide clinical practice in the care of heart disease with particular interest in care of the athletic heart, cardiovascular prevention and echocardiography. He is also interested in medical education and is involved in teaching medical students, residents and fellows. Dr Jacobsen is board certified in Internal Medicine and board eligible in Cardiovascular Disease and Echocardiography.

Education History

Fellowship Johns Hopkins Hospital
Fellow
Johns Hopkins Hospital
Resident
Residency Mayo Clinic
Resident
University College Hospital Galway
Resident
Internship Mater Misericordiae University Hospital
Intern
National University of Ireland, Galway
MB, BCh, BAO

Selected Publications

Journal Article

  1. Raber I, Belanger MJ, Farahmand R, Aggarwal R, Chiu N, Al Rifai M, Jacobsen AP, Lipsitz LA, Juraschek SP (2022). Orthostatic Hypotension in Hypertensive Adults: Harry Goldblatt Award for Early Career Investigators 2021. Hypertension, 79(11), 2388-2396. (Read full article)
  2. Jacobsen AP, Khiew YC, Duffy E, OConnell J, Brown E, Auwaerter PG, Blumenthal RS, Schwartz BS, McEvoy JW (2022). Climate change and the prevention of cardiovascular disease. Am J Prev Cardiol, 12, 100391. (Read full article)
  3. Jacobsen AP, McKittrick M, Daya N, Al Rifai M, McEvoy JW (2022). Response to Isolated Diastolic Hypertension and Risk of Cardiovascular Disease: Controversies in Hypertension - Con Side of the Argument. Hypertension, 79(8), 1570. (Read full article)
  4. Jacobsen AP, McKittrick M, Daya N, Al Rifai M, McEvoy JW (2022). Isolated Diastolic Hypertension and Risk of Cardiovascular Disease: Controversies in Hypertension-Con Side of the Argument. Hypertension, 79(8), 1571-1578. (Read full article)
  5. Jacobsen AP, Lim ZL, Chang B, Lambeth KD, Das TM, Gorry C, McCague M, Sharif F, Mylotte D, Wijns W, Serruys PWJC, Blumenthal RS, Martin SS, McEvoy JW (2022). Contextualizing National Policies Regulating Access to Low-Dose Aspirin in America and Europe Using the Full Report of a Transatlantic Patient Survey of Aspirin in Preventive Cardiology. J Am Heart Assoc, 11(8), e023995. (Read full article)
  6. Jacobsen AP, Blumenthal RS (2021). Cardiovascular Disease Is the Condition, Air Pollution the Risk Factor, Fossil Fuel Combustion the Cause. J Am Coll Cardiol, 79(2), e131. (Read full article)
  7. Gaffney B, Jacobsen AP, Pallippattu AW, Leahy N, McEvoy JW (2021). The Diastolic Blood Pressure J-Curve in Hypertension Management: Links and Risk for Cardiovascular Disease. Integr Blood Press Control, 14, 179-187. (Read full article)
  8. Jacobsen AP, Lim ZL, Chang B, Lambeth KD, Das TM, Gorry C, McCague M, Wijns W, Serruys PWJC, Blumenthal RS, Martin SS, McEvoy JW (2021). A Transatlantic Comparison of Patient-Reported Access to and Use of Aspirin in Contemporary Preventive Cardiology. J Am Coll Cardiol, 78(11), 1193-1195. (Read full article)
  9. Jacobsen AP, Robledo-Gil T, Nahas-Vigon JH, Epstein JA, Berger ZD, Sufrin CB (2021). Care for Incarcerated Patients Hospitalized with COVID-19. J Gen Intern Med, 36(7), 2094-2099. (Read full article)
  10. Jacobsen AP, Al Rifai M, Arps K, Whelton SP, Budoff MJ, Nasir K, Blaha MJ, Psaty BM, Blumenthal RS, Post WS, McEvoy JW (2020). A cohort study and meta-analysis of isolated diastolic hypertension: searching for a threshold to guide treatment. Eur Heart J, 42(21), 2119-2129. (Read full article)
  11. Prendiville T, Tanner R, Jacobsen AP, Margey R, McGorrian C, Casserly IP (2021). Safety of Conscious Sedation for Transcatheter Aortic Valve Replacement Without an Anesthetist. J Invasive Cardiol, 33(3), E220-E224. (Read full article)
  12. Jacobsen AP, Raber I, McCarthy CP, Blumenthal RS, Bhatt DL, Cusack RW, Serruys PWJC, Wijns W, McEvoy JW (2020). Lifelong Aspirin for All in the Secondary Prevention of Chronic Coronary Syndrome: Still Sacrosanct or Is Reappraisal Warranted? Circulation, 142(16), 1579-1590. (Read full article)
  13. Jacobsen AP, Epstein JA (2020). Dying Without COVID-19: End-of-Life Care for an Uninfected Incarcerated Patient. Mayo Clin Proc, 95(10), 2286-2288. (Read full article)
  14. Rabbitt L, Byrne D, OConnor P, Gorecka M, Jacobsen A, Lydon S (2020). A pragmatic randomised controlled trial of SAFMEDS to produce fluency in interpretation of electrocardiograms. BMC Med Educ, 20(1), 102. (Read full article)
  15. Jacobsen AP, McEvoy JW (2019). Changing place for aspirin in primary prevention of cardiovascular disease. Drug Ther Bull, 58(1), 3-4. (Read full article)
  16. Natoni A, Coyne MR, Jacobsen A, Rainey MD, OBrien G, Healy S, Montagnoli A, Moll J, ODwyer M, Santocanale C (2013). Characterization of a Dual CDC7/CDK9 Inhibitor in Multiple Myeloma Cellular Models. Cancers (Basel), 5(3), 901-18. (Read full article)